Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Dermatology
FDA Approves Mirvaso, First and Only Treatment Available for Erythema in Rosacea
Read More
Dermatology
Emerging Therapies for the Treatment of Rosacea
Read More
Access and the Affordable Care Act
Read More
ACOs Challenges in Oncology Care
Read More
Keeping up with Clinical Pathways
Read More
Value Propositon of Personalized Medicine
Read More
Lessons Learned Through Payer-Provider Collaborations
Read More
Medical Adherence Programs and Tools
Read More
Pathways as a Tool to Reduce Variances and Costs
Read More
Payer-Provider Collaborations in Cancer Care
Read More
164
165
166
167
168
169
170
Page 167 of 244
Results 1661 - 1670 of 2434